A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of the study is to compare the plasma drug levels of PF-04447943 when taken as a 35 mg tablet after a high fat meal compared to when taken after fasting. Healthy adult volunteers will receive a single dose of the drug once when fasted and again when fed. The safety and tolerability of the drug will be monitored.

Key facts

Study ID

NCT00886093

Run by

Pfizer

People needed

10

Starts

2009-04-01

Expected to finish

2009-05-01

Last updated by the study team

2009-07-02

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and/or female subjects, not of child bearing potential.
• Age 18-55 inclusive
• Total body weight >50 kg.

You may not qualify if…

• Evidence or history of clinical significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic diseases
• History of orthostatic blood pressure changes or orthostatic symptoms
• Greater than 7 drinks of alcohol per week for women and greater than 14 drinks per week for men
• Smoking more than 5 cigarettes per day

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.